Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

Thromb Res. 2017 Oct:158:152-153. doi: 10.1016/j.thromres.2017.09.009. Epub 2017 Sep 8.

Authors

Mariasanta Napolitano¹, Sergio Siragusa²

Affiliations

¹ Dipartimento Biomedico di Medicina Interna e Specialistica, UOC Ematologia con Trapianto, Università di Palermo, Palermo, Italy.
² Dipartimento Biomedico di Medicina Interna e Specialistica, UOC Ematologia con Trapianto, Università di Palermo, Palermo, Italy. Electronic address: [email protected].

PMID: 28917114
DOI: 10.1016/j.thromres.2017.09.009

No abstract available

Keywords: Bleeding; Cancer associated thrombosis; Low molecular weight heparin; Recurrences; Tinzaparin.

Publication types

Editorial

MeSH terms

Anticoagulants / pharmacology
Anticoagulants / therapeutic use*
Humans
Neoplasms / drug therapy*
Neoplasms / pathology

Substances

Anticoagulants